Treatment of alpha-Galactosidase A deficiency

Details for Australian Patent Application No. 2004242550 (hide)

Owner Transkaryotic Therapies, Inc.

Inventors Daniel, Peter F; Schuetz, Thomas J; Williams, Melanie D; Treco, Douglas A; Kinoshita, Carol M; Borowski, Marianne; Selden, Richard F

Agent Davies Collison Cave

Pub. Number AU-A-2004242550

Parent 35194

Filing date 31 December 2004

Wipo publication date 27 January 2005

Acceptance publication date 3 April 2008

International Classifications

C12N 009/00 Enzymes, e.g. ligases (6.)

Event Publications

20 January 2005 Complete Application Filed

27 January 2005 Application Open to Public Inspection

  Published as AU-A-2004242550

7 June 2007 Change of Name(s) of Applicant(s), Section 104

  Transkaryotic Therapies Inc. The name of the applicant has been changed to Shire Human Genetic Therapies, Inc.

3 April 2008 Application Accepted

  Published as AU-A-2004242550

31 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004242551-Web servers with queryable dynamic caches

2004242549-Enhanced approach of m-array decoding and error correction